(PharmaNewsWire.Com, June 23, 2017 ) The Middle East and Africa Respiratory Monitoring Devices market is estimated to reach USD 1.22 billion by 2021 from a market value of USD 0.91 billion in 2016 at a CAGR of 6.07%. Respiratory Monitoring Devices are used to measure the amount of air we inhale or exhale, Amount of oxygen present in blood or the Amount of carbon dioxide.
Respiratory Diseases are rising ceaselessly in view of reduction in air quality, urbanization and Deforestation. Rise in number of smokers all around is additionally a reason for growing respiratory diseases. Respiratory Monitoring Devices rise due to the ascent in respiratory diseases and high clinical costs. With Respiratory Monitoring Devices, Clinical care is moved to home care.
There are many factors that are driving this market like, Prevalence of COPD Globally, Development of advanced Technology, rise in number of Smokers, increase in aging population and rise in healthcare expenditure in emerging countries. But factors like huge price of Monitoring Devices and increased complexity are restraining the market growth. Undeveloped market in this region is restricting the growth of market.
Middle East and Africa Respiratory Monitoring Devices Market is segmented based on Diagnostic and Monitoring Devices. Based on Diagnostic Devices, market is segmented into spirometers, and peak flow meter. Based on Monitoring Devices, market is segmented into sleep test devices, gas analyzers, pulse oximeters, and capnograph. Pulse Oximeters dominate the market because of their accurate and fast results. Pulse oximeter is expected to be top segment for the coming years too because of its better diagnostic results compared to others.
Geographically, this market is further segmented in to Middle East and Africa. This market has the least share compared to other regions and Low CAGR which is because lack of advanced technology and absence of key players.
Key players in this market are Covidien GE Healthcare, Philips Healthcare, Siemens Healthcare, Resmed, Merck & Co. Inc, Calondo Pharmaceuticals Inc., Quark Pharmaceuticals Inc., Access Pharmaceuticals Inc., Sirnaomics Inc., and Traversa Therapeutics Inc.
About Market Data Forecast: The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Global among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
